Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

455.70
Delayed Data
As of May 25
 -2.54 / -0.55%
Today’s Change
325.35
Today|||52-Week Range
464.40
+24.14%
Year-to-Date

Today’s Trading

Previous close458.24
Today’s open460.04
Day’s range455.02 - 460.04
Volume671,881
Average volume (3 months)913,553
Market cap$48.4B
Dividend yield--
Data as of 05/25/2017

Growth & Valuation

Earnings growth (last year)+39.49%
Earnings growth (this year)+13.45%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+18.44%
P/E ratio55.1
Price/Sales8.79
Price/Book10.86

Competitors

 Today’s
change
Today’s
% change
SHPGShire-0.53-0.29%
BAXBaxter International...+0.80+1.37%
ZTSZoetis Inc+0.28+0.45%
VRTXVertex Pharmaceutica...+0.80+0.68%
Data as of 05/25/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$3.18
Annual revenue (last year)$4.9B
Annual profit (last year)$895.5M
Net profit margin18.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts